12,372 trials
Optic Neuritis
Primary: Retinal Nerve Fiber Layer Thickness at Baseline and Month 6 — 128.1; 130.5; 89.5; 88.0 µm
Autoimmune Diseases · Renal Disorders · Hematologic Disorders
Primary: Percent Efficiency of Plasma Removal During the Therapeutic Plasma Exchange Procedure — 81.9; 75.2 percentage of plasma removal efficiency — p=<0.001
Constipation
Primary: Change of Mucus and Mucin Secretion in Patients With Chronic Constipation and in Controls. — 260; 133; 229; 161 mg/hour
Pneumococcal Vaccines · Pneumococcal Conjugate Vaccine
Primary: Serotype-specific Opsonophagocytic Activity (OPA) Geometric Mean Titers (GMTs) for 12 Common Serotypes 1 Month After Vaccination — 103; 78; 44; 61 titer
Infections, Papillomavirus
Primary: Number of Subjects With Any, Grade 3 and Related Serious Adverse Events (SAEs) — 8; 5; 0 Subjects
Alzheimer's Disease · Mild Cognitive Impairment
Primary: Qualitative Amyloid Image Assessment — 12; 5; 3; 3 participants — p=0.0253
Head and Neck Cancer
Primary: Relapse Free Survival — 30; 28 participants
Glaucoma · Ocular Hypertension
Primary: Change From Baseline in Mean Diurnal Intraocular Pressure (IOP) in the Study Eye — 22.35; -3.98 Millimeters of Mercury (mmHg)
Fallopian Tube Clear Cell Adenocarcinoma · Fallopian Tube Endometrioid Adenocarcinoma · Fallopian Tube Mucinous Adenocarcinoma
Primary: Progression-free Survival — 11.0; 12.3; 15.3 months — p=0.448
Fallopian Tube Cancer · Primary Peritoneal Cavity Cancer · Recurrent Ovarian Epithelial Cancer
Primary: Median Progression-free Survival — 3.2; 4.5 months
HIV Infections
Primary: HIV Infection in Infants Determined to be HIV Uninfected at 6 Weeks Enrolled in Each Arm of the Study — 8; 18; 700; 699 participants — p=0.049
Type2 Diabetes · High Blood Sugar
Primary: Proportion of Participants With Adverse Events — 79.1; 72.4 Percentage of participants
Hepatitis C, Chronic
Primary: Percentage of Participants Who Experienced at Least 1 Adverse Event. — 80.0 Percentage of participants
Tobacco Dependence
Primary: Tobacco Abstinence at 12 Weeks — 8; 5 participants
Acute Upper Respiratory Tract Infection
Primary: Summary Scores on the SUM8 Daily Cough and Phlegm Diary Card On the Morning of Day 4 — 12.96; 12.87; 12.71 units on a scale